ABOUT · About Us

Connecting health. Bringing silent data back into decision-making.

With “Connecting Health” as its mission, the company draws on its founding team’s deep expertise in the internet and artificial intelligence and more than a decade of focus on digital and intelligent transformation in the broader healthcare industry. With StarPlex, its pharmaceutical AI agent platform, at the core, it helps the broader healthcare industry turn “silent data assets” into “data productivity.”

10+
Years of Focus on the Broader Healthcare Industry
2015
Company Founded
01 · Who We Are

Your AI-Powered Data Intelligence Partner

Weiming Penguin uses AI-native technology to rebuild industry databases for the broader healthcare industry, providing end-to-end big data products and solutions spanning data integration, governance, insights, and decision support for the industry.

Building a closed-loop business intelligence process of “data — analysis — decision-making — execution” to help the broader healthcare industry turn “silent data assets” into “data productivity.”

Academic Depth Technology at Our Core AI-Native Pharmaceutical Focus Over a Decade of Experience
02 · Our Journey

From Our Founding to Today

Over ten years, we have grown from a technology team into an AI-powered data intelligence partner.

Weiming Penguin incorporated

2015
2016

Raised tens of millions in angel funding led by Matrix Partners China

Raised tens of millions in Series A funding led by Chengwei Capital

Raised tens of millions in Series B funding led by Redstone Capital

Acquired Shandong Youdu

2017
2018

Recognized as a National Technology-Based Small and Medium-Sized Enterprise

Repeatedly recognized as a Technology-Based Small and Medium-Sized Enterprise

2019
2020

Provided pro bono support for the “Wuhan Emergency Medical and Epidemic Prevention Supplies Procurement System” during the pandemic

Continued to deepen its expertise in data governance for the pharmaceutical and broader healthcare industries

2021
2022

Launched StarPlex, its pharmaceutical AI agent platform, fully embracing the AI-native era

03 · Leadership Team

Built on internet-era thinking, empowered by AI-native technology, and focused on digital and intelligent transformation in the broader healthcare industry.

01
Dr. Zou Xiaoliang
Founder & CEO
Doctorate, National School of Development, Peking University & Fordham University, United States
Visiting Professor at Inner Mongolia University of Technology; Distinguished Instructor at Tencent Academy; Visiting AI Researcher at Tencent Research Institute; Instructor for the Entrepreneur AI Program at the National School of Development, Peking University; Expert at Caixin Think Tank; Senior Vice President of the China Association of Pharmaceutical Commerce
Former faculty member at Inner Mongolia University of Technology, Business Intelligence Director at Alibaba Group, and Deputy General Manager at Tencent Group
02
Tian Ying
Co-Founder & President
Bachelor’s Degree in Software Engineering, Tongji University · Master’s Degree in Financial Engineering, Peking University
20 years of strategic leadership experience in the internet and pharmaceutical and healthcare sectors, dedicated to using technology to enable digital transformation and help businesses move from an “experience-driven” model to an “AI-driven, value-anticipating” paradigm
Six years of prior experience as a product manager at NetEase and an analyst at Tencent
03
Bao Guohui
Vice President, R&D & Operations
Bachelor’s Degree in Computer Science and Technology, Dalian Naval Academy
Over 20 years, progressed from a “technical practitioner” to a “hands-on leader in the AI era,” focusing on deeply integrating AI technology with business use cases
Former Project Manager / R&D Team Lead for parenting products at the Innovative Business Center of Tencent’s Dalian R&D Center
04
Li Weibo
Vice President, Sales
Bachelor’s Degree in Computer Science and Technology, Shenyang Agricultural University
19 years of cross-industry experience in quality and compliance management; led the development and implementation of end-to-end quality systems at BOE Software Group and for Tencent internet products serving hundreds of millions of users
Dedicated to advancing pharmaceutical digital transformation by redesigning AI DevOps processes and implementing comprehensive compliance monitoring, shifting quality management from “after-the-fact interception” to “proactive prevention”
05
Geng Yuehui
Vice President, Finance
Bachelor’s Degree in Management, Renmin University of China
20 years of experience in financial strategy and management; led the operation of complex financial systems at major state-owned enterprises
Skilled at combining AI and data analytics to drive AI-Driven Finance transformation, shifting financial management from “recording value” to “creating and anticipating value”
06
Yang Dingming
Co-Founder & Vice President
Master’s Degree, Beijing University of Technology
18 years of experience in internet data intelligence services and business design, with extensive work for industry leaders including Tencent and Yidao Yongche
Focused on driving business value through data by building end-to-end data service systems and intelligent operations, progressing from accumulated data assets to a closed-loop business decision-making process
04 · Credentials & Honors

Technical expertise, backed by evidence.

National-Level
Technology-Based Small and Medium-Sized Enterprise
Certification
MLPS Level 3
Information Security Compliance
Note: The credentials and honors above are based on the company’s actual registration records. Technology-Based Small and Medium-Sized Enterprise status is assessed through the relevant information platform of China’s Ministry of Science and Technology. MLPS Level 3 certification information can be verified through official Chinese public security authority channels.

If you also believe data should return to the heart of decision-making.

Join Us